Gold prices just lower; monthly gains on track
Investing.com - Harrow Health reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Harrow Health announced earnings per share of $-0.240 on revenue of $22.8M. Analysts polled by Investing.com EPS of $-0.010 on revenue of $23.14M.
Harrow Health 's are down 63% and is trading at $11.600 , still down 12.69% from its 52 week high of $13.29 set on Monday, October 3, 2022.
Harrow Health follows other major Healthcare sector earnings this month
Harrow Health's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar